UniVessel SU: Sartorius Stedim Biotech Develops Next Generation Of Its Successful Single-Use Laboratory Bioreactor
Sartorius Stedim Biotech (SSB), a leading international equipment provider for the biopharmaceutical industry, presents UniVessel SU, the second generation of its successful single-use bioreactor.
Therapure Biopharma Inc. Awarded US Government Contract For Development Of Anti-Nerve Gas Agent
Mississauga, Ontario, Canada -- Therapure Biopharma Inc., a contract development and manufacturing organization (CDMO) of biotherapeutics, is pleased to announce the company will participate as a subcontractor for DynPort Vaccine Company LLC (DVC), a CSC company, that was awarded a US cost-plus-fixed-fee contract with a maximum value of $157.3 million (prime contract number W911QY-13-C-0056) by the US Department of Defense (DoD) to support the development of a prophylactic countermeasure to prevent the effects of organophosphorus nerve agent poisoning.
Patheon To Host Complimentary Seminar On 'Formulation, Funding And First-In-Man: A Stepwise Guide To Clinical Success'
Patheon will host a complimentary seminar on “Formulation, Funding and First-in-Man: A Stepwise Guide to Clinical Success”. The seminar will be held on Tuesday, June 25, 2013 at 11:30 a.m. to 5:30 p.m., Central European Time, at the Hilton Hotel in Basel, Switzerland.
Event To Highlight 'Product Enhancement Through Complex Dosage Forms: Adding Value To Products’ Lifecycle Management'
Patheon is sponsoring and event to highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”. The complimentary seminar will be held on Tuesday, June 18, 2013 at 8 a.m. Eastern Daylight Time at the MassBio Headquarters in Cambridge, Massachusetts.
As The First Biopharmaceutical Company Worldwide, apceth Receives Approval For A Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells For The Treatment Of Cancer
As the first biopharmaceutical company worldwide, apceth GmbH & Co. KG with its headquarters and manufacturing sites in Munich and Ottobrunn (near Munich) has received approval to conduct a clinical cancer trial with its genetically modified, adult mesenchymal stem cells.
Cubist Names Dr. Lorianne Masuoka Chief Medical Officer
Cubist Pharmaceuticals, Inc. recently announced the appointment of Dr. Lorianne Masuoka to Chief Medical Officer and Senior Vice President, Clinical Development and Medical Affairs.
Finesse Solutions Launches TruBio DV 4.6 SCADA Software And SmartOPC Servers For Overlay On Applikon And Sartorius Bioreactor Controllers
Finesse Solutions, Inc., Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the release of TruBio DV version 4.6 Supervisory Control And Data Acquisition (SCADA) software, which has been developed to harmonize and upgrade an installed base of older, proprietary bioreactor controllers.
ATMI Opens Laboratory For Bioprocess Application Support At Bloomington, MN Site
ATMI, Inc., a global technology company and leader in single-use bioprocess solutions, announced recently the opening of a United States-based laboratory for applications development and testing.
Agilent Technologies Demonstrates New Generation Of Ion Mobility Technology To Enhance High-Resolution Mass Spectrometry Capabilities
Agilent Technologies Inc. Recently introduced analytical research findings using new ion mobility technology combined with a modified high-resolution iFunnel Quadrupole-Time-of-Fight LC/MS system.
BioTek Instruments Announces Establishment Of Japanese Office
BioTek Instruments, Inc., continues their global expansion in the microplate-based technology market with the establishment of BioTek Japan.